Insider Trading History of Brown Bob D

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Brown Bob D since 1. This trader's CIK number is 1598479. At the time of last reporting, Brown Bob D was the Chief Scientific Ofr., EVP R&D of Dicerna Pharmaceuticals Inc. (stock ticker symbol DRNA). Also see all insider trading activities at Dicerna Pharmaceuticals Inc.



Yearly summary of insider trading at Dicerna Pharmaceuticals Inc (DRNA) by Brown Bob D

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 DRNA 0 $0 163,496 $4,926,608 143,863 $864,867
2020 DRNA 0 $0 126,267 $2,851,529 147,784 $489,108
2019 DRNA 0 $0 34,747 $762,723 30,077 $96,095
2019 DRNA 0 $0 34,747 $762,723 30,077 $96,095
2018 DRNA 0 $0 9,669 $145,035 0 $0


Insider trading of Dicerna Pharmaceuticals Inc (DRNA) by Brown Bob D

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-12-15 DRNA Option Ex 3,775 .00 0
2021-11-18 DRNA Option Ex 24,936 3.42 85,281
2021-11-18 DRNA Sale 24,936 37.94 946,071
2021-09-17 DRNA Sale 21,250 21.06 447,525
2021-08-02 DRNA Option Ex 8,312 3.42 28,427
2021-08-02 DRNA Sale 8,312 37.38 310,677
2021-07-01 DRNA Option Ex 8,312 3.42 28,427
2021-07-01 DRNA Sale 8,312 37.58 312,323
2021-06-11 DRNA Sale 10,000 34.00 340,000
2021-06-11 DRNA Option Ex 10,000 9.09 90,900
2021-06-07 DRNA Option Ex 10,000 9.09 90,900
2021-06-07 DRNA Sale 10,000 33.00 330,000
2021-06-01 DRNA Option Ex 8,312 3.42 28,427
2021-06-01 DRNA Sale 8,312 31.45 261,404
2021-04-30 DRNA Sale 10,000 32.00 320,000
2021-04-29 DRNA Sale 10,000 31.00 310,000
2021-04-30 DRNA Option Ex 10,000 9.09 90,900
2021-04-29 DRNA Option Ex 10,000 9.09 90,900
2021-04-01 DRNA Option Ex 8,312 3.42 28,427
2021-04-01 DRNA Sale 8,312 26.18 217,566
2021-03-01 DRNA Sale 8,312 29.20 242,677
2021-03-01 DRNA Option Ex 8,312 9.09 75,556
2021-02-03 DRNA Sale 8,312 25.00 207,800
2021-02-03 DRNA Option Ex 8,312 9.09 75,556
2021-01-25 DRNA Sale 21,630 25.00 540,750
2021-01-25 DRNA Option Ex 16,630 9.09 151,166
2021-01-12 DRNA Sale 5,808 24.07 139,815
2021-01-08 DRNA Option Ex 8,650 .00 0
2020-12-01 DRNA Option Ex 8,185 3.42 27,992
2020-12-01 DRNA Sale 8,185 25.19 206,204
2020-11-02 DRNA Option Ex 8,185 3.42 27,992
2020-11-02 DRNA Sale 8,185 21.03 172,130
2020-10-16 DRNA Option Ex 16,370 3.42 55,985
2020-10-16 DRNA Sale 16,370 21.00 343,770
2020-09-16 DRNA Option Ex 21,250 3.42 72,675
2020-09-14 DRNA Option Ex 267 3.42 913
2020-08-03 DRNA Sale 8,185 22.57 184,719
2020-08-03 DRNA Option Ex 8,185 3.42 27,992
2020-07-01 DRNA Option Ex 8,185 3.42 27,992
2020-07-01 DRNA Sale 8,185 26.61 217,778
2020-06-19 DRNA Sale 9,670 25.00 241,750
2020-06-19 DRNA Option Ex 9,670 2.97 28,719
2020-06-01 DRNA Option Ex 8,185 3.42 27,992
2020-06-01 DRNA Sale 8,185 21.01 171,958
2020-05-11 DRNA Option Ex 13,281 2.97 39,444
2020-05-11 DRNA Sale 13,281 24.00 318,744
2020-05-05 DRNA Option Ex 8,185 3.42 27,992
2020-05-05 DRNA Sale 8,185 21.00 171,885
2020-04-17 DRNA Option Ex 8,185 3.42 27,992
2020-04-20 DRNA Sale 13,281 23.00 305,463
2020-04-20 DRNA Option Ex 13,281 2.97 39,444
2020-04-17 DRNA Sale 8,185 21.18 173,358
2020-03-02 DRNA Option Ex 8,185 3.42 27,992
2020-03-02 DRNA Sale 8,185 21.00 171,885
2020-02-10 DRNA Option Ex 8,185 3.42 27,992
2020-02-10 DRNA Sale 8,185 21.00 171,885
2019-12-31 DRNA Sale 11,941 22.00 262,702
2019-12-30 DRNA Sale 22,806 21.93 500,021
2019-12-31 DRNA Option Ex 16,941 3.19 54,126
2019-12-30 DRNA Option Ex 13,136 3.19 41,969
2018-05-09 DRNA Sale 9,669 15.00 145,035
2019-12-31 DRNA Sale 11,941 22.00 262,702
2019-12-30 DRNA Sale 22,806 21.93 500,021
2019-12-30 DRNA Option Ex 13,136 3.19 41,969
2019-12-31 DRNA Option Ex 16,941 3.19 54,126

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Brown Bob D (Chief Scientific Ofr., EVP R&D of Dicerna Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.